{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:02:18Z","timestamp":1779714138295,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.7759\/cureus.109602","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:05:42Z","timestamp":1779710742000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effectiveness of Antihypertensive Agents vs. Control in the Prevention and Management of Preeclampsia: A Network Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Ali S","family":"Metwaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhal","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham O","family":"AlSubhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Elzahra  S","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A","family":"Khawaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer J","family":"Zakrait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar A","family":"Albehairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanouf B","family":"Hosioi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil  E","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-34103-8_9","article-title":"Preeclampsia in pregnancy: diagnosis, management, and future implications for maternal health","author":"Williams A","year":"2023","unstructured":"Williams A, Naert M, Berhie S. Preeclampsia in pregnancy: diagnosis, management, and future implications for maternal health. Contemporary Topics in Cardio-Obstetrics. Sharma G, Scott NS, Davis MB, Economy KE (ed): Springer Nature, Switzerland; 2023. 139-55. 10.1007\/978-3-031-34103-8_9"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002252.pub3","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos E","year":"2014","unstructured":"Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014, CD002252. 10.1002\/14651858.CD002252.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.18920","article-title":"Role of antihypertensive treatment and blood pressure control in the occurrence of adverse pregnancy outcomes: a population-based study of linked electronic health records","volume":"79","author":"Al Khalaf S","year":"2022","unstructured":"Al Khalaf S, Khashan AS, Chappell LC, O'Reilly \u00c9J, McCarthy FP. Role of antihypertensive treatment and blood pressure control in the occurrence of adverse pregnancy outcomes: a population-based study of linked electronic health records. Hypertension. 2022, 79:1548-58. 10.1161\/HYPERTENSIONAHA.122.18920","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-83434-0_40","article-title":"Perinatology","author":"Voto LS","year":"2022","unstructured":"Voto LS, Zeitune MG. Perinatology. Perinatology. Moreira de S\u00e1 RA, Fonseca EB (ed): Springer Nature, Switzerland; 2022. 155. 10.1007\/978-3-030-83434-0_40"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0581","article-title":"Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia","volume":"18","author":"Ma S","year":"2023","unstructured":"Ma S, Zhu L, Zhou T, Qi T, Wang W. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia. Open Life Sci. 2023, 18:20220581. 10.1515\/biol-2022-0581","journal-title":"Open Life Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.04.011","article-title":"Oral antihypertensive treatment during pregnancy: a systematic review and network meta-analysis","volume":"233","author":"Hup RJ","year":"2025","unstructured":"Hup RJ, Damen JA, Terstappen J, et al.. Oral antihypertensive treatment during pregnancy: a systematic review and network meta-analysis. Am J Obstet Gynecol. 2025, 233:250-62. 10.1016\/j.ajog.2025.04.011","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24013","article-title":"The impact of antihypertensive treatment of mild to moderate hypertension during pregnancy on maternal and neonatal outcomes: an updated meta-analysis of randomized controlled trials","volume":"46","author":"Attar A","year":"2023","unstructured":"Attar A, Hosseinpour A, Moghadami M. The impact of antihypertensive treatment of mild to moderate hypertension during pregnancy on maternal and neonatal outcomes: an updated meta-analysis of randomized controlled trials. Clin Cardiol. 2023, 46:467-76. 10.1002\/clc.24013","journal-title":"Clin Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","volume":"223","author":"Bellos I","year":"2020","unstructured":"Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D, Daskalakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol. 2020, 223:525-37. 10.1016\/j.ajog.2020.03.016","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18415","article-title":"Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses","volume":"79","author":"Bone JN","year":"2022","unstructured":"Bone JN, Sandhu A, Abalos ED, et al.. Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses. Hypertension. 2022, 79:614-28. 10.1161\/HYPERTENSIONAHA.121.18415","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13030091","article-title":"Efficacy and safety of nifedipine compared to intravenous hydralazine for severe hypertensive disorders in pregnancy: a systematic review and meta-analysis of randmomized controlled trials","volume":"13","author":"Govindasamy V","year":"2025","unstructured":"Govindasamy V, Kamel MA, Volucke G, et al.. Efficacy and safety of nifedipine compared to intravenous hydralazine for severe hypertensive disorders in pregnancy: a systematic review and meta-analysis of randmomized controlled trials. Med Sci (Basel). 2025, 13:91. 10.3390\/medsci13030091","journal-title":"Med Sci (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-69700-9_13","article-title":"The treatment of preeclampsia in poor and rich countries","author":"Wacker J","year":"2024","unstructured":"Wacker J, Nwaeburu L, N'Diaye A. The treatment of preeclampsia in poor and rich countries. Global Women's Health. Wacker J, et al. (ed): Springer, Berlin; 2024. 161-73. 10.1007\/978-3-662-69700-9_13"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh ML","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012, 22:276-82. 10.11613\/bm.2012.031","journal-title":"Biochem Med (Zagreb)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref16","unstructured":"R Core Team. R. a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2026). https:\/\/www.R-project.org\/."},{"key":"ref17","unstructured":"netmeta. network meta-analysis using frequentist methods. R package version 2.8-1. (2023). https:\/\/cran.r-project.org\/web\/packages\/netmeta\/index.html."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout J","year":"2016","unstructured":"IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016, 6:e010247. 10.1136\/bmjopen-2015-010247","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins JP","year":"2012","unstructured":"Higgins JP, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012, 3:98-110. 10.1002\/jrsm.1044","journal-title":"Res Synth Methods"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias S","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29:932-44. 10.1002\/sim.3767","journal-title":"Stat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker G","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015, 15:58. 10.1186\/s12874-015-0060-8","journal-title":"BMC Med Res Methodol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani A","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013, 8:e76654. 10.1371\/journal.pone.0076654","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from\u00a0a network meta-analysis","volume":"93","author":"Brignardello-Petersen R","year":"2018","unstructured":"Brignardello-Petersen R, Bonner A, Alexander PE, et al.. Advances in the GRADE approach to rate the certainty in estimates from\u00a0a network meta-analysis. J Clin Epidemiol. 2018, 93:36-44. 10.1016\/j.jclinepi.2017.10.005","journal-title":"J Clin Epidemiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","article-title":"A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension","volume":"99","author":"Pickles CJ","year":"1992","unstructured":"Pickles CJ, Broughton Pipkin F, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol. 1992, 99:964-8. 10.1111\/j.1471-0528.1992.tb13698.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref25","article-title":"Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy","volume":"49","author":"Rezaei Z","year":"2011","unstructured":"Rezaei Z, Sharbaf FR, Pourmojieb M, Youefzadeh-Fard Y, Motevalian M, Khazaeipour Z, Esmaeili S. Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. Acta Med Iran. 2011, 49:701-6.","journal-title":"Acta Med Iran"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/npmj.npmj_275_20","article-title":"Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy. A randomised controlled trial","volume":"27","author":"Adebayo JA","year":"2020","unstructured":"Adebayo JA, Nwafor JI, Lawani LO, Esike CO, Olaleye AA, Adiele NA. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy. A randomised controlled trial. Niger Postgrad Med J. 2020, 27:317-24. 10.4103\/npmj.npmj_275_20","journal-title":"Niger Postgrad Med J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.018","article-title":"Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial","volume":"217","author":"Sharma C","year":"2017","unstructured":"Sharma C, Soni A, Gupta A, Verma A, Verma S. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. Am J Obstet Gynecol. 2017, 217:687.e1-6. 10.1016\/j.ajog.2017.08.018","journal-title":"Am J Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13569","article-title":"Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial","volume":"123","author":"Magee LA","year":"2016","unstructured":"Magee LA, von Dadelszen P, Singer J, et al.. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016, 123:1143-51. 10.1111\/1471-0528.13569","journal-title":"BJOG"},{"key":"ref29","article-title":"Intravenous labetalol vs oral nifedipine in acute severe hypertension of pregnancy - a randomized controlled trial","author":"Azmat B","year":"2018","unstructured":"Azmat B, Sharma A, Singh P. Intravenous labetalol vs oral nifedipine in acute severe hypertension of pregnancy - a randomized controlled trial. J Cardiovasc Dis Res. 2018, 159-64.","journal-title":"J Cardiovasc Dis Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10006-2602","article-title":"Intravenous labetalol vs oral nifedipine in acute severe hypertension in pregnancy: a randomized controlled trial","volume":"17","author":"Raja GPT","year":"2025","unstructured":"Raja GPT, Patil KP, Metgud MC, Savanur M, Malapure A, Hanji V. Intravenous labetalol vs oral nifedipine in acute severe hypertension in pregnancy: a randomized controlled trial. J South Asian Feder Obst Gynae. 2025, 17:1-4. 10.5005\/jp-journals-10006-2602","journal-title":"J South Asian Feder Obst Gynae"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91297-p","article-title":"A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy","volume":"162","author":"Sibai BM","year":"1990","unstructured":"Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990, 162:960-7. 10.1016\/0002-9378(90)91297-p","journal-title":"Am J Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a9ea68","article-title":"Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial","volume":"122","author":"Shekhar S","year":"2013","unstructured":"Shekhar S, Sharma C, Thakur S, Verma S. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol. 2013, 122:1057-63. 10.1097\/AOG.0b013e3182a9ea68","journal-title":"Obstet Gynecol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion ST","year":"1999","unstructured":"Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999, 181:858-61. 10.1016\/s0002-9378(99)70314-5","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.03151.x","article-title":"Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial","volume":"119","author":"Raheem IA","year":"2012","unstructured":"Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012, 119:78-85. 10.1111\/j.1471-0528.2011.03151.x","journal-title":"BJOG"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20150011","article-title":"A comparative randomized controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of mild preeclampsia","volume":"4","author":"Singhal S","year":"2015","unstructured":"Singhal S, Gupta AK. A comparative randomized controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of mild preeclampsia. Int J Basic Clin Pharmacol. 2015, 4:442-5. 10.18203\/2319-2003.ijbcp20150011","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(99)70315-7","article-title":"A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies","volume":"181","author":"Scardo JA","year":"1999","unstructured":"Scardo JA, Vermillion ST, Newman RB, Chauhan SP, Hogg BB. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1999, 181:862-6. 10.1016\/s0002-9378(99)70315-7","journal-title":"Am J Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13337.x","article-title":"Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial","volume":"107","author":"Hall DR","year":"2000","unstructured":"Hall DR, Odendaal HJ, Steyn DW, Smith M. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. BJOG. 2000, 107:759-65. 10.1111\/j.1471-0528.2000.tb13337.x","journal-title":"BJOG"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia","volume":"81","author":"Aali BS","year":"2002","unstructured":"Aali BS, Nejad SS. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. Acta Obstet Gynecol Scand. 2002, 81:25-30. 10.1034\/j.1600-0412.2002.810105.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.05.009","article-title":"Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: a multicenter randomized clinical trial","volume":"17","author":"Salama M","year":"2019","unstructured":"Salama M, Rezk M, Gaber W, Hamza H, Marawan H, Gamal A, Abdallah S. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: a multicenter randomized clinical trial. Pregnancy Hypertens. 2019, 17:54-8. 10.1016\/j.preghy.2019.05.009","journal-title":"Pregnancy Hypertens"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19751","article-title":"Trial of intrapartum extended-release nifedipine to prevent severe hypertension among pregnant individuals with preeclampsia with severe features","volume":"80","author":"Cleary EM","year":"2023","unstructured":"Cleary EM, Racchi NW, Patton KG, Kudrimoti M, Costantine MM, Rood KM. Trial of intrapartum extended-release nifedipine to prevent severe hypertension among pregnant individuals with preeclampsia with severe features. Hypertension. 2023, 80:335-42. 10.1161\/HYPERTENSIONAHA.122.19751","journal-title":"Hypertension"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita AT","year":"2022","unstructured":"Tita AT, Szychowski JM, Boggess K, et al.. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022, 386:1781-92. 10.1056\/NEJMoa2201295","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005613","article-title":"Pregnancy outcomes of nifedipine compared with labetalol for oral treatment of mild chronic hypertension","volume":"144","author":"Sanusi AA","year":"2024","unstructured":"Sanusi AA, Leach J, Boggess K, et al.. Pregnancy outcomes of nifedipine compared with labetalol for oral treatment of mild chronic hypertension. Obstet Gynecol. 2024, 144:126-34. 10.1097\/AOG.0000000000005613","journal-title":"Obstet Gynecol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling T","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, et al.. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019, 394:1011-21. 10.1016\/S0140-6736(19)31282-6","journal-title":"Lancet"},{"key":"ref44","unstructured":"A randomised parallel-group trial for comparison of safety and efficacy of oral nifedipine retard versus intravenous labetalol in management of hypertensive emergencies of pregnancy. (2024). https.\/\/zenodo.org\/records\/15487876."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.25259\/IJMA_660","article-title":"A comparative study of oral nifedipine and intravenous labetalol for acute hypertensive management in pregnancy: assessing feto-maternal outcomes in a hospital-based randomized control trial","volume":"13","author":"Kaur T","year":"2024","unstructured":"Kaur T, Kumari K, Rai P, Gupta V, Pandey S, Vineeta, Saini S. A comparative study of oral nifedipine and intravenous labetalol for acute hypertensive management in pregnancy: assessing feto-maternal outcomes in a hospital-based randomized control trial. Int J MCH AIDS. 2024, 13:e011. 10.25259\/IJMA_660","journal-title":"Int J MCH AIDS"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2024\/67570.19213","article-title":"Comparison of the efficacy of labetalol and nifedipine in preeclampsia: a prospective interventional study","volume":"18","author":"Nimbark N","year":"2024","unstructured":"Nimbark N, Sharma R, Jain S. Comparison of the efficacy of labetalol and nifedipine in preeclampsia: a prospective interventional study. J Clin Diagn Res. 2024, 18:14-7. 10.7860\/JCDR\/2024\/67570.19213","journal-title":"J Clin Diagn Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.55489\/ijmr.1202202455","article-title":"Comparative efficacy and safety of oral labetalol and nifedipine in the management of preeclampsia: a randomized controlled trial","volume":"12","author":"Jhaveri P","year":"2024","unstructured":"Jhaveri P, Shah D, Chauhan K. Comparative efficacy and safety of oral labetalol and nifedipine in the management of preeclampsia: a randomized controlled trial. Int J Med Res. 2024, 12:18-25. 10.55489\/ijmr.1202202455","journal-title":"Int J Med Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20191962","article-title":"Comparative study of labetalol and nifedipine in management of non-severe preeclampsia and its fetomaternal outcome","volume":"8","author":"Rose DT","year":"2019","unstructured":"Rose DT, Jeyarani P. Comparative study of labetalol and nifedipine in management of non-severe preeclampsia and its fetomaternal outcome. Int J Reprod Contracept Obstet Gynecol. 2019, 8:2034-8. 10.18203\/2320-1770.ijrcog20191962","journal-title":"Int J Reprod Contracept Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495499-comparative-effectiveness-of-antihypertensive-agents-vs-control-in-the-prevention-and-management-of-preeclampsia-a-network-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:05:43Z","timestamp":1779710743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495499-comparative-effectiveness-of-antihypertensive-agents-vs-control-in-the-prevention-and-management-of-preeclampsia-a-network-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.109602","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}